ABBOTT LABORATORIES (PUERTO RICO) INCORPORATED

ABBOTT LABORATORIES (PUERTO RICO) INCORPORATED operates as a manufacturer within the pharmaceutical and medical product sector, specializing in the production of diagnostic reagents, laboratory equipment, and healthcare-related pharmaceuticals under NAICS 325412. The company’s core capabilities center on cGMP-compliant manufacturing processes, sterile product formulation, quality control systems, and regulatory documentation for FDA-regulated products. Technical expertise includes process validation, aseptic processing, analytical method development, and supply chain integrity for in-vitro diagnostics and therapeutic agents. Specializations lie in scalable biopharmaceutical production and maintaining compliance with 21 CFR Part 211 and ISO 13485 standards, ensuring consistent product quality for sensitive medical applications. Award history is not available to infer specific agency relationships or contract patterns. Consequently, no direct evidence exists regarding engagement with federal departments or defense, health, or research agencies. The company’s primary industry focus is pharmaceutical manufacturing, specifically the production of diagnostic kits, lab-based reagents, and precision pharmaceuticals. This positions Abbott Laboratories (Puerto Rico) as a critical node in the domestic medical supply chain, supporting clinical laboratories, hospitals, and regulatory-compliant distribution networks. The vertical specialization lies in high-volume, low-margin precision manufacturing requiring stringent environmental controls and traceability. The entity is structured as a 2L corporation with its operational base in San Juan, Puerto Rico. It holds no active government certifications such as 8(a), HUBZone, or SDVOSB. Its geographic presence is concentrated in Puerto Rico, serving as a manufacturing hub for the U.S. pharmaceutical market with an emphasis on regulatory adherence and production reliability rather than federal contracting visibility.